Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Researchers made two new compounds that could be used for medicine.

A bald man grew hair on his head after taking a drug called diazoxide, but lost it again when he stopped the medication.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The new compound may be a safer alternative to finasteride for prostate protection.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

A new compound shows promise as a topical treatment for hair loss.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Fetal exposure to diazoxide can cause hair loss and abnormal hair growth in infants.

A new method to make finasteride for hair loss treatment was developed.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.